Your browser doesn't support javascript.
loading
Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).
Voegeli, Michèle; Rondeau, Stephanie; Berardi Vilei, Simona; Lerch, Erika; Wannesson, Luciano; Pabst, Thomas; Rentschler, Jochen; Bargetzi, Mario; Jost, Lorenz; Ketterer, Nicolas; Bischof Delaloye, Angelika; Ghielmini, Michele.
Afiliación
  • Voegeli M; Medizinische Universitätsklinik, Liestal, Switzerland.
  • Rondeau S; SAKK Coordinating Center, Bern, Switzerland.
  • Berardi Vilei S; SAKK Coordinating Center, Bern, Switzerland.
  • Lerch E; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Wannesson L; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.
  • Pabst T; Inselspital Bern, Bern, Switzerland.
  • Rentschler J; Universitätsspital Basel, Basel, Switzerland.
  • Bargetzi M; Ortenau Klinikum Offenburg, Offenburg, Germany.
  • Jost L; Kantonsspital Aarau, Aarau, Switzerland.
  • Ketterer N; Kantonsspital Bruderholz, Bruderholz, Switzerland.
  • Bischof Delaloye A; CHUV, Lausanne, Switzerland.
  • Ghielmini M; Hirslanden Lausanne SA, Lausanne, Switzerland.
Hematol Oncol ; 35(4): 576-583, 2017 Dec.
Article en En | MEDLINE | ID: mdl-27677906
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Linfoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Hematol Oncol Año: 2017 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Linfoma Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Hematol Oncol Año: 2017 Tipo del documento: Article País de afiliación: Suiza